Epidemiological and clinicopathological characteristics of vascular-limited renal AL amyloidosis
Noémie Senot(Hôpital Européen Georges-Pompidou), Camille Cohen(Inserm), Nathanaël Beeker(Hôpital Cochin), Hélène Perrochia(Centre Hospitalier Universitaire de Montpellier), Kathleen Dessaix(Hôpital Necker-Enfants Malades), Magali Colombat(Centre Hospitalier Universitaire de Toulouse), Elsa Ferrière(Hôpital Necker-Enfants Malades), Benjamin Carpentier, Nicolas Wayolle(Centre Hospitalier de Béthune), Mathieu Wémeau(Inserm), Pierre Pinson(Imperial College London), Marion Rabant(Hôpital Necker-Enfants Malades), Frank Bridoux(Université de Poitiers), Jean Michel Goujon(Université de Poitiers), Emmanuel Estève(Inserm), Jean Baptiste Gibier(Centre Hospitalier Universitaire de Lille), Jérôme Olagne(Université de Strasbourg)
Cited by 3
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
|American Journal of Transplantation|2016|625